Showing 61-70 of 747 results for "".
- WCD News: Janssen's Oral IL-23 Blocker Shows Promise in Phase 2b PsO Studyhttps://practicaldermatology.com/news/wcd-news/2461839/Janssen’s novel oral interleukin-23 receptor (IL-23R) antagonist peptide JNJ-2113 performed well in the Phase 2b FRONTIER 1 clinical trial of adults with moderate-to-severe plaque psoriasis (PsO), the Company reports. JNJ-2113 is a novel oral IL-23R antagonist peptide that binds w
- ASA Awards: Jon M. Hanifin, MD, Wins David Martin Carter Mentor Awardhttps://practicaldermatology.com/news/asa-awards-jon-m-hanifin-md-wins-david-martin-carter-mentor-award/2461728/The American Skin Association (ASA) announced the recipients of the 2023 David Martin Carter Mentor Award, 2023 George W. Hambrick Award, and the 2023 Research Achievement Awards at the International Societies for Investigative Dermatology (ISID) in Tokyo, Japan. <
- UCB’s Bimekizumab Performs Well in PsA Studieshttps://practicaldermatology.com/news/ucbs-bimekizumab-performs-well-in-psa-studies/2461460/Two new studies highlight the efficacy and safety of bimekizumab in the treatment of adults with active psoriatic arthritis who were biologic-naïve and/or tumor necrosis factor inhibitor inadequate responders (TNFi-IR). The 24-week results from the Phase 3 BE OPTIMAL study and 16-w
- Crown CFO to Take on COO Role Toohttps://practicaldermatology.com/news/crown-cfo-to-take-on-coo-role-too/2461259/Crown Laboratories Chief Financial Officer (CFO) Nadeem Moiz will take on expanded responsibilities as Chief Operations Officer (COO). This appointment is made as Jack Songster, Crown's current COO, is set to retire on July 15. In this dual role, Mr. Moiz w
- DermWire Special Report: JAK Inhibitors in Dermatologyhttps://practicaldermatology.com/news/dermwire-special-report-jak-inhibitors-in-dermatology/2460916/By Denise Mann, Editor at Large Lots of hope is pinned on Janus kinase (JAK) inhibitors for the treatment of atopic dermatitis (AD), alopecia areata, vitiligo, plus other skin diseases, and the pipeline is full. Will the recent FDA decision to expand the boxed w
- Bausch Health Plans IPO of Solta Medical Aesthetics Unithttps://practicaldermatology.com/news/bausch-health-plans-ipo-of-solta-medical-aesthetics-unit/2460880/Bausch Health Companies Inc. is planning to pursue an initial public offering (IPO) of its Solta Medical business. Solta’s portfolio includes the Thermage RF systems, Fraxel laser, Clear + Brilliant laser and VASER ultrasonic systems. The timing of the anticipated IPO, w
- AAD: Sixty Percent of Americans Have Gotten Sunburned So Badly Their Clothes Were Uncomfortablehttps://practicaldermatology.com/news/aad-sixty-percent-of-americans-have-gotten-sunburned-so-badly-their-clothes-were-uncomfortable/2460396/Most Americans say they have gotten a sunburn and admit it has impacted their day-to-day life, according to a recent AAD survey. Of those who have been sunburned, 60 percent said their sunburns made their clothes uncomfortable; 43 percent said they couldn’t sleep; and 21 percent said they w
- Destiny Pharma and MedPharm Complete Initial Phase of Development Projecthttps://practicaldermatology.com/news/destiny-pharma-and-medpharm-complete-initial-phase-of-development-project/2460318/Destiny Pharma and MedPharm have completed the initial phase of their project to develop new topical formulations of Destiny’s novel XF‐platform drugs. Further to forming the collaboration with MedPharm last year, the project has identified a range of new, stable XF formulations w
- Special to Practical Dermatology: ACS Chief Medical Officer Sounds Off On Sunscreen Misusehttps://practicaldermatology.com/news/special-to-practical-dermatology-acs-chief-medical-officer-sounds-off-on-sunscreen-misuse/2457647/We are getting it all wrong when it comes to our reliance on sunscreen as the be all and end all protection from skin cancer, says Otis W. Brawley, MD, chief medical and scientific officer for the American Cancer Society in Atlanta. Sunscreen wasn’t developed so we could all get a f
- Sciton Rewards Consumer in New Sweepstakeshttps://practicaldermatology.com/news/sciton-rewards-consumer-in-new-sweepstakes/2458143/Consumers can win $1,000 towards one of several Sciton treatments including Halo, BBL, Contour TRL, and diVa Laser Vaginal Therapy as part of an ongoing national sweepstakes. The Sciton consumer sweepstakes runs through August 23, with one w